Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04920058 · ClinicalTrials.gov registry record · NA
Optimal Metabolic Health Through Continuous Glucose Monitoring
A NA study, sponsored by University of South Florida.
- Completed
- Registry status
- NA
- Development phase
- 66
- Enrollment target
NCT04920058: Completed NA study, sponsored by University of South Florida.
NCT04920058 is a NA study that has completed, run by University of South Florida. The registered enrollment target is 66 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04920058, a NA study, has completed, sponsored by University of South Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 66 participants
- Enrollment target
Study Summary
The primary focus of this study is to evaluate the role of Continuous Glucose Monitoring (CGM) with Levels Health software as a tool to provide feedback and accountability necessary to create sustainable behavioral changes in nutrition associated with improved metabolic health and resilience against chronic and infectious diseases.
Primary Outcome
The intervention arm will have Continuous Glucose Monitoring (CGM) data collected over 12 weeks per protocol design. Subjects will be considered stable with no more than a 10% increase in average CGM from baseline. This outcome with be presented as mean glucose and Hba1c concentration as well as the number of subjects that improved average CGM from baseline.
Interventions
- DEVICE Continuous Glucose Monitor
- OTHER <Active Comparator?>
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2021-05-10 |
| Est. Completion | 2022-04-18 |
| Phase | NA |
What the finished NCT04920058 record still lists
NCT04920058 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 66 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 2 interventions - of which Continuous Glucose Monitor is the first listed.
NCT04920058 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04920058 about?
NCT04920058 is a clinical study titled "Optimal Metabolic Health Through Continuous Glucose Monitoring". The primary focus of this study is to evaluate the role of Continuous Glucose Monitoring (CGM) with Levels Health software as a tool to provide feedback and accountability necessary to create sustainable behavioral changes in nutrition associated with improved metabolic health and resilience against...
What is the current status of trial NCT04920058?
This trial is currently completed. It is a NA study. The enrollment target is 66 participants. The study started on 2021-05-10. Estimated completion is 2022-04-18.
What interventions are being tested in trial NCT04920058?
The interventions under investigation include: Continuous Glucose Monitor (DEVICE), <Active Comparator?> (OTHER).
Who is sponsoring clinical trial NCT04920058?
This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04920058's enrollment target sits among peer trials
66 1139th of 2000 higher than 857 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02584244 · 66 participants · Phase 1
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
- NCT03067051 · 66 participants · Phase 1
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
- NCT03754725 · 66 participants · Phase 1
Ferritin and Iron Burden in SAH sIRB
- NCT03875378 · 66 participants · Phase 2
Transdermal Estrogen in Women With Anorexia Nervosa
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI